US2023340427A1PendingUtilityA1

L-glutamate dehydrogenase mutant and application thereof

Assignee: ABIOCHEM BIOTECHNOLOGY CO LTDPriority: Apr 3, 2018Filed: Mar 14, 2023Published: Oct 26, 2023
Est. expiryApr 3, 2038(~11.7 yrs left)· nominal 20-yr term from priority
C12N 9/0028C12P 13/04C12N 9/0016C12Y 104/01004
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided are an L-glutamate dehydrogenase mutant and an application thereof, the mutant mutating the amino acid residue A at position 166 and/or the amino acid residue V at position 376 shown in SEQ ID NO. 1 into a hydrophilic or small sterically hindered amino acid residue, the application performing an amination reaction of 2-oxo-4-(hydroxymethylphosphinyl)butyrate in the presence of an L-amino acid dehydrogenase mutant, an inorganic amino donor, and a reduced coenzyme NADPH, and performing an acidification reaction on the obtained L-glufosinate salt to obtain L-glufosinate. Compared to wild L-glutamate dehydrogenase, the present L-glutamate dehydrogenase mutant has a higher concentration of substrates that can be catalysed when preparing L-glufosinate, thereby increasing the efficiency of the action of the enzyme and reducing reaction costs.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . An L-glutamate dehydrogenase mutant, wherein the amino acid sequence of the L-glutamate dehydrogenase mutant is SEQ ID NO: 36 or SEQ ID NO: 38. 
     
     
         2 . The L-glutamate dehydrogenase mutant of  claim 1 , wherein the amino acid sequence of the L-glutamate dehydrogenase mutant is SEQ ID NO: 36. 
     
     
         3 . The L-glutamate dehydrogenase mutant of  claim 1 , wherein the amino acid sequence of the L-glutamate dehydrogenase mutant is SEQ ID NO: 38. 
     
     
         4 . An isolated nucleic acid comprising a nucleotide sequence encoding the L-glutamate dehydrogenase mutant of  claim 1 . 
     
     
         5 . A method for producing an L-glufosinate salt, wherein the method comprises the following step: combining the L-glutamate dehydrogenase mutant of  claim 1 , 2-oxo-4-(hydroxymethylphosphinyl) butyrate, an inorganic amino donor, and NADPH in a reaction solvent to produce the L-glufosinate salt. 
     
     
         6 . The method of  claim 5 , wherein the method further comprises the following step: combining a D-glufosinate salt with a D-amino acid oxidase to produce the 2-oxo-4-(hydroxymethylphosphinyl) butyrate. 
     
     
         7 . The method of  claim 6 , wherein the method comprises one or more of the following conditions:
 the D-glufosinate salt is purified or is mixed with an L-glufosinate salt;   the D-amino acid oxidase has a concentration of 0.6-6 U/mL;   the combining is performed in the presence of oxygen;   the combining is performed in the presence of catalase;   the D-glufosinate salt has a concentration of 100-600 mM;   a pH of 7-9; and   a temperature of 20-50° C.   
     
     
         8 . The method of  claim 5 , wherein the method comprises one or more of the following conditions:
 the L-glutamate dehydrogenase mutant has a concentration of 0.09-3 U/ml;   the inorganic amino donor has a concentration of 100-2000 mM;   the 2-oxo-4-(hydroxymethylphosphinyl) butyrate has a concentration of 100-600 mM;   the molar ratio of NADPH to the 2-oxo-4-(hydroxymethylphosphinyl) butyrate is 1:30000-1:1000;   the inorganic amino donor is one or more of ammonia, ammonium sulfate, ammonium chloride, diammonium hydrogen phosphate, ammonium acetate, ammonium formate, and ammonium bicarbonate;   the reaction solvent is water;   a pH of 7-9; and   a temperature of 20-50° C.   
     
     
         9 . The method of  claim 5 , wherein the method further comprises the following step: the NADPH is oxidized to NADP +  and the NADP +  is reduced to NADPH by a dehydrogenase and a hydrogen donor. 
     
     
         10 . The method of  claim 9 , wherein the method comprises one or more of the following conditions:
 the dehydrogenase that reduces NADP +  to NADPH has a concentration of 0.6-6 U/mL;   the NADP +  has a concentration of 0.02-0.1 mM;   the hydrogen donor has a concentration of 100-1000 mM;   a pH of 7-9; and   the reduction reaction has a reaction system with a temperature of 20-50° C.   
     
     
         11 . The method of  claim 9 , wherein the dehydrogenase that reduces NADP +  to NADPH is a glucose dehydrogenase, an alcohol dehydrogenase or a formate dehydrogenase;
 or, the hydrogen donor is a glucose, isopropanol or formate.

Join the waitlist — get patent alerts

Track US2023340427A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.